Why the FDA is warning pregnant women not to use over-the-counter pain relievers
- Written by C. Michael White, Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut

The Food and Drug Administation issued a warning on Oct. 15, 2020 to both health care professionals and women about the use of nonsteroidal anti-inflammatory drugs (NSAIDs) after 20 weeks of pregnancy.
This comes after the FDA added its post-marketing surveillance...
Read more: Why the FDA is warning pregnant women not to use over-the-counter pain relievers